Key result
Ivabradine provides defined heart rate-lowering benefits with specific trade-offs in chronic heart failure.
Why the study?
Aspects of heart rate-lowering therapy with ivabradine in chronic heart failure patients require discussion regarding its advantages, disadvantages, and treatment role.
This review discusses the advantages, disadvantages, and clinical role of ivabradine in the management of chronic heart failure.
Answers are grounded in this paper and cite their sources.
May inform ivabradine selection in chronic HF; leaves open its optimal place in contemporary regimens.
Aspects of heart rate-lowering therapy in patients with chronic heart failure using If-channel blocker ivabradine are discussed. The evidence-based data on ivabradine use reveal its advantages, disadvantages and place in the treatment of cardiac patients.
No takes yet. Share an insight, caveat, or question.
Шалаев et al. (2015) studied this question. Heart rate-lowering therapy with the If-channel blocker ivabradine has established advantages, disadvantages, and a defined clinical role in the treatment of chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: